Featured Research

from universities, journals, and other organizations

Stat3 Signaling Tips The Balance Of Immunity In Favor Of Cancer

Date:
February 3, 2009
Source:
Cell Press
Summary:
New research reveals how a cancer-associated protein enables tumor cells to evade the immune system by both suppressing anti-tumor influences and promoting tumor-enhancing conditions, in essence turning the immune system to the dark side of the force. The study is published by Cell Press in the Feb. 3 issue of the journal Cancer Cell.

New research reveals how a cancer-associated protein enables tumor cells to evade the immune system by both suppressing antitumor influences and promoting tumor-enhancing conditions, in essence turning the immune system to the dark side of the force. The study is published by Cell Press in the February 3rd issue of the journal Cancer Cell.

Related Articles


Continuous activation of the transcription factor Stat3 contributes to the survival and proliferation of cancer cells. Activated Stat3 suppresses antitumor activity by stimulating immunosuppressive factors and by inhibiting expression of chemicals that are critical for antitumor immunity. In addition to tumor cells themselves, Stat3 is activated in many different types of immune cells present in the tumor microenvironment, such as macrophages and dendritic cells, facilitating the crosstalk between tumor cells and tumor-associated immune cells.

Recent research has suggested that the cytokine IL-23 has tumor-promoting effects while the closely related cytokine IL-12 has anti-tumor characteristics. "Although results from previous studies have suggested that IL-23 and IL-12 may play opposite roles in cancer progression, the specific mechanisms of action in tumor regulation have not been elucidated," explains study author Dr. Drew Pardoll from the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University School of Medicine.

Drs. Hua Yu, Marcin Kortylewski and Hong Xin from the Beckman Research Institute at City of Hope in Duarte, California and Dr. Pardoll, investigated how IL-23 and IL-12 are differentially regulated in the tumor microenvironment. The researchers found that Stat3 induced expression of IL-23 in tumor-associated macrophages and inhibited expression of IL-12 in tumor-associated dendritic cells.

Unexpectedly, IL-23 receptor was upregulated in regulatory T cells within the tumor microenvironment and enhanced their immunosuppressive activity. In these cells, the IL-23 receptor activates Stat3 and leads to production of the immunosuppressive cytokine IL-10.

Taken together, these findings demonstrate that Stat3 promotes IL-23-related pro-cancer immune responses and concurrently inhibits IL-12-dependent antitumor immunity. "Because Stat3 is a point of convergence for signaling pathways commonly activated in cancer, our data reveal a mechanism by which oncogenic pathways regulate the immune microenvironment to promote tumor development," concludes Dr. Yu.

The researchers include Marcin Kortylewski, Department of Cancer Immunotherapeutics and Tumor Immunology, Beckman Research Institute at City of Hope, Duarte, CA; Hong Xin, Department of Cancer Immunotherapeutics and Tumor Immunology, Beckman Research Institute at City of Hope, Duarte, CA; Maciej Kujawski, Department of Cancer Immunotherapeutics and Tumor Immunology, Beckman Research Institute at City of Hope, Duarte, CA; Heehyoung Lee, Department of Cancer Immunotherapeutics and Tumor Immunology, Beckman Research Institute at City of Hope, Duarte, CA; Yong Liu, Department of Cancer Immunotherapeutics and Tumor Immunology, Beckman Research Institute at City of Hope, Duarte, CA; Timothy Harris, Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University School of Medicine, Baltimore, MD; Charles Drake, Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University School of Medicine, Baltimore, MD; Drew Pardoll, Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University School of Medicine, Baltimore, MD; and Hua Yu, Department of Cancer Immunotherapeutics and Tumor Immunology, Beckman Research Institute at City of Hope, Duarte, CA.


Story Source:

The above story is based on materials provided by Cell Press. Note: Materials may be edited for content and length.


Cite This Page:

Cell Press. "Stat3 Signaling Tips The Balance Of Immunity In Favor Of Cancer." ScienceDaily. ScienceDaily, 3 February 2009. <www.sciencedaily.com/releases/2009/02/090202174457.htm>.
Cell Press. (2009, February 3). Stat3 Signaling Tips The Balance Of Immunity In Favor Of Cancer. ScienceDaily. Retrieved March 30, 2015 from www.sciencedaily.com/releases/2009/02/090202174457.htm
Cell Press. "Stat3 Signaling Tips The Balance Of Immunity In Favor Of Cancer." ScienceDaily. www.sciencedaily.com/releases/2009/02/090202174457.htm (accessed March 30, 2015).

Share This


More From ScienceDaily



More Health & Medicine News

Monday, March 30, 2015

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Soda, Salt and Sugar: The Next Generation of Taxes

Soda, Salt and Sugar: The Next Generation of Taxes

Washington Post (Mar. 30, 2015) — Denisa Livingston, a health advocate for the Dinι Community Advocacy Alliance, and the Post&apos;s Abby Phillip discuss efforts around the country to make unhealthy food choices hurt your wallet as much as your waistline. Video provided by Washington Post
Powered by NewsLook.com
UnitedHealth Buys Catamaran

UnitedHealth Buys Catamaran

Reuters - Business Video Online (Mar. 30, 2015) — The $12.8 billion merger will combine the U.S.&apos; third and fourth largest pharmacy benefit managers. Analysts say smaller PBMs could also merge. Fred Katayama reports. Video provided by Reuters
Powered by NewsLook.com
S. Leone in New Anti-Ebola Lockdown

S. Leone in New Anti-Ebola Lockdown

AFP (Mar. 28, 2015) — Sierra Leone imposed a three-day nationwide lockdown Friday for the second time in six months in a bid to prevent a resurgence of the deadly Ebola virus. Duration: 01:17 Video provided by AFP
Powered by NewsLook.com
These Popular Antibiotics Can Cause Permanent Nerve Damage

These Popular Antibiotics Can Cause Permanent Nerve Damage

Newsy (Mar. 27, 2015) — A popular class of antibiotic can leave patients in severe pain and even result in permanent nerve damage. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:

Strange & Offbeat Stories

 

Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins